The antibody repertoire of colorectal cancer
Seong Won ChaiD, Stefano R. BonissoneiD, Seungjin NaiD, Pavel A. PevzneriD, Vineet BafnaiD
Abstract
3Immunotherapy is becoming increasingly important in the fight against cancers, utilizing and manipulating the bodys immune response to treat tumors. Understanding the immune repertoire - the collection of immunological proteins - of treated and untreated cells is possible at the genomic, but technically difficult at the protein level. Standard protein databases do not include the highly divergent sequences of somatic rearranged immunoglobulin genes, and may lead to missed identifications in a mass spectrometry search. We introduce a novel proteogenomic approach, AbScan, to identify these highly variable antibody peptides, by developing a customized antibody database construction method using RNA-seq reads aligned to immunoglobulin (Ig) genes.\n\nAbScan starts by filtering transcript (RNA-seq) reads that match the template for Ig genes. The retained reads are used to construct a repertoire graph using the split de Bruijn graph: a graph structure that improves upon the standard de Bruijn graph to capture the high diversity of Ig genes in a compact manner. AbScan corrects for sequencing errors, and converts the graph to a format suitable for searching with MS/MS search tools. We used AbScan to create an antibody database from 90 RNA-seq colorectal tumor samples. Next, we used proteogenomics analysis to search MS/MS spectra of matched colorectal samples from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) against the AbScan generated database. AbScan identified 1, 940 distinct antibody peptides. Correlating with previously identified Single Amino-Acid Variants (SAAVs) in the tumor samples, we identified 163 pairs (antibody peptide, SAAV) with significant co-occurrence pattern in the 90 samples. The presence of co-expressed antibody and mutated peptides was correlated with survival time of the individuals. Our results suggest that AbScan(https://github.com/csw407/AbScan.git) is an effective tool for a proteomic exploration of the immune response in cancers.\n\n\n\nO_TBL View this table:\norg.highwire.dtl.DTLVardef@62001corg.highwire.dtl.DTLVardef@1f542faorg.highwire.dtl.DTLVardef@10048d0org.highwire.dtl.DTLVardef@1ac5a75org.highwire.dtl.DTLVardef@66db0f_HPS_FORMAT_FIGEXP M_TBL C_TBL
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 12
- FWCI
- 0.27
- Field percentile
- top 49%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Systemic antibody repertoires target specific microbial antigens in patients with colorectal cancer
Gabriel Innocenti, Stefanie Brezina, … Thomas J. Vogl·bioRxiv·Oct 19, 2026
- Antibody landscape of C57BL/6 mice cured of B78 melanoma via immunotherapy
A. Hoefges, S. J. McIlwain, … P. M. Sondel·bioRxiv·Feb 24, 2023
- Serum proteomics expands on high-affinity antibodies in immunized rabbits than deep B-cell repertoire sequencing alone
S. R. Bonissone, T. Lima, … A. Patel·bioRxiv·Jan 31, 2020
- Improvement in Neoantigen Prediction via Integration of RNA Sequencing Data for Variant Calling
B. Q. T. Nguyen, T. P. D. Tran, … L. S. Tran·bioRxiv·Jul 2, 2023
- The common neoantigens in colorectal cancer are predicted and validated to be presented or immunogenic
- Proteogenomic analysis reveals RNA as an important source for tumor-agnostic neoantigen identification correlating with T-cell infiltration
C. Tretter, N. de Andrade Kraetzig, … A. M. Krackhardt·bioRxiv·Sep 17, 2022